PRESS RELEASE published on 01/20/2024 at 16:03, 10 months 1 day ago ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX The Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of BioNTech SE (NASDAQ: BNTX) securities. The lawsuit alleges that BioNTech made materially false and misleading statements regarding its business, operations, and prospects, resulting in damages to investors. Investors are encouraged to secure qualified counsel before the important deadline. For more information on the class action, including how to join and the details of the case, visit the specified website or contact the Rosen Law Firm directly. Rosen Law Firm BioNTech SE Investor Rights Class Action Lawsuit Securities Fraud
PRESS RELEASE published on 01/20/2024 at 16:03, 10 months 1 day ago ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important January 30 Deadline in Securities Class Action - LPSN The Rosen Law Firm, a global investor rights law firm, is reminding investors of the important January 30, 2024 lead plaintiff deadline in the securities class action against LivePerson, Inc. If you purchased LivePerson securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. For more information on how to join the class action, visit https://rosenlegal.com/submit-form/?case_id=20829. The Rosen Law Firm represents investors worldwide, concentrating its practice in securities class actions and shareholder derivative litigation, with a strong track record of success in leadership roles. Rosen Law Firm Securities Class Action Investor Rights LivePerson Securities Securing Counsel
PRESS RELEASE published on 01/20/2024 at 15:04, 10 months 1 day ago ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BRBS Rosen Law Firm, a global investor rights law firm, is reminding investors of Blue Ridge Bankshares, Inc. (NYSE American: BRBS) about the important February 5, 2024 lead plaintiff deadline in the securities class action. Investors may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Visit the Rosen Law Firm website or call for information on the class action and the lead plaintiff requirements. The lawsuit alleges that Blue Ridge Bankshares, Inc. made materially false and/or misleading statements and/or failed to disclose certain errors in its financial statements, which resulted in damages to investors. Rosen Law Firm Securities Class Action Investor Rights Lead Plaintiff Deadline Blue Ridge Bankshares
PRESS RELEASE published on 01/20/2024 at 14:05, 10 months 1 day ago ROSEN, A TOP RANKED LAW FIRM, Encourages Assertio Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ASRT The Rosen Law Firm, a top-ranked global investor rights law firm, is encouraging Assertio Holdings, Inc. investors who incurred losses during a specific period to secure legal counsel before an important deadline in a securities class action. The firm emphasizes the need for qualified counsel with a proven track record of success in leadership roles and highlights its achievements in securities class actions and shareholder derivative litigation, including the largest ever securities class action settlement against a Chinese company. The lawsuit alleges that Assertio made materially false and misleading statements regarding its business, operations, and prospects, resulting in damages to investors. The Rosen Law Firm provides detailed information on how investors can join the class action and emphasizes that until a class is certified, individuals are not represented by counsel unless they retain one. Rosen Law Firm Securities Class Action Investor Rights Lead Plaintiff Deadline Assertio Holdings Inc
PRESS RELEASE published on 01/20/2024 at 02:34, 10 months 1 day ago ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Future FinTech Group Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - FTFT Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of purchasers of the securities of Future FinTech Group Inc. (NASDAQ: FTFT) for potential securities law violations. Investors who purchased Future FinTech securities during the class period may be entitled to compensation and are encouraged to seek legal counsel before the important deadline. The Rosen Law Firm has a strong track record in securities class actions and represents investors throughout the globe. Rosen Law Firm Securities Class Action Investor Rights Financial Litigation Future FinTech Group Inc.
PRESS RELEASE published on 01/20/2024 at 02:34, 10 months 1 day ago NATIONALLY RANKED ROSEN LAW FIRM Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - EH Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of EHang Holdings Limited of the lead plaintiff deadline in a securities class action. Investors are encouraged to secure qualified counsel before the important deadline and may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The firm has a successful track record in securities class actions and shareholder derivative litigation, having achieved the largest ever securities class action settlement against a Chinese Company and recovered hundreds of millions of dollars for investors. Interested parties can join the class action by contacting the firm for more information. Rosen Law Firm Securities Class Action Investor Rights EHang Holdings Limited Securities Litigation
PRESS RELEASE published on 01/20/2024 at 02:34, 10 months 1 day ago GNRC MONDAY DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Generac Holdings Inc. Investors with Losses to Secure Counsel Before Important January 22 Deadline in Securities Class Action - GNRC Rosen Law Firm, a global investor rights law firm, reminds Generac Holdings Inc. investors of the important January 22, 2024 lead plaintiff deadline in the securities class action. Investors who purchased Generac common stock between May 3, 2023 and August 3, 2023 may be entitled to compensation and are encouraged to select qualified counsel to represent their interests. Rosen Law Firm Securities Class Action Investor Rights Compensation Generac Holdings Inc.
PRESS RELEASE published on 01/20/2024 at 02:34, 10 months 1 day ago ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DRVN The Rosen Law Firm, a global investor rights law firm, encourages Driven Brands Holdings Inc. investors to seek legal counsel before the important February 20, 2024, deadline in the securities class action lawsuit. Investors who purchased Driven Brands common stock between October 27, 2021, and August 1, 2023, may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The lawsuit alleges that the defendants made false and misleading statements related to the integration of acquired businesses and the performance of Driven's car wash business segment. To join the Driven Brands class action or for more information, visit https://rosenlegal.com/submit-form/?case_id=18662 or contact Phillip Kim, Esq. at 866-767-3653 or email pkim@rosenlegal.com. The Rosen Law Firm represents investors globally and has a strong track record in securities class actions and shareholder derivative litigation. Rosen Law Firm Securities Class Action Driven Brands Holdings Inc. Investor Rights Law Firm Shareholder Derivative Litigation
PRESS RELEASE published on 01/20/2024 at 02:34, 10 months 1 day ago ROSEN, NATIONAL TRIAL LAWYERS, Encourages Dollar General Corporation Investors to Secure Counsel Before Important January 26 Deadline in Securities Class Action - DG Rosen Law Firm, a global investor rights law firm, is encouraging Dollar General Corporation investors to secure counsel before the important January 26 deadline in a securities class action. Purchasers of Dollar General common stock between May 28, 2020, and August 30, 2023, may be entitled to compensation and should consider joining the class action. The firm has a track record of success in leadership roles and represents investors in securities class actions and shareholder derivative litigation, having achieved significant settlements for investors in the past. Rosen Law Firm Securities Class Action Investor Rights Shareholder Derivative Litigation Dollar General Corporation
PRESS RELEASE published on 01/20/2024 at 02:33, 10 months 1 day ago ROSEN, A LEADING NATIONAL FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) of the important February 9, 2024 lead plaintiff deadline. If you purchased Eagle Pharmaceuticals securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. To join the Eagle Pharmaceuticals class action, visit Rosen Legal's website or contact their team for information on the class action. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm Securities Class Action Investor Rights Lead Plaintiff Deadline Eagle Pharmaceuticals
Published on 11/21/2024 at 22:05, 1 hour 47 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 2 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 37 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 3 hours 42 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 3 hours 52 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:01, 4 hours 51 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 16 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 5 hours 53 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 1 minute ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 16 hours 54 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo